FAG
NURO

Fortitude Advisory Group’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Fortitude Advisory Group’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed – – 1389
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1614
2021
Q4 		$0 Buy
+1
New +$59 ﹤0.01% 1568

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fortitude Advisory Group's NURO Position: Q2 2022 in Review

Fortitude Advisory Group sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2022, closing a stake of 1 share.

Fortitude Advisory Group first reported a position in NURO in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 17 funds tracked by Wall St. Rank hold NURO as of Q2 2022.

  • Fortitude Advisory Group reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 1 NeuroMetrix, Inc. Common Stock share in Q2 2022.
  • Fortitude Advisory Group first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's NeuroMetrix, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.